Purchase Order 15B41226P00000030
- Not listed
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a firm fixed price purchase order valued at $43,869.35 to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy. Pantherx Specialty is a specialty pharmacy that is a subsidiary of Centene Corporation. The purchase order is to provide Pantherx JOENJA medication to inmates at the Federal Medical Center Rochester from August 17, 2023 through September 1, 2023. The place of performance is the...
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $43,869.35 firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy and a subsidiary of Centene Corporation, for pharmacy services. The order is for Pantherx to provide pharmaceutical products and services to inmates at the Federal Medical Center Rochester facility in Pittsburgh, Pennsylvania from July 31, 2023 through August 4, 2023. As the Bureau of Prisons...
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $43,869.35 firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy and a subsidiary of Centene Corporation, for pharmaceutical products and services. The contract has a period of performance from July 3, 2023 through July 10, 2023 to support the Bureau of Prisons' healthcare programs at its Pittsburgh, Pennsylvania facility. No subcontractors or set aside...
- The U.S. Federal Medical Center Rochester, a civilian facility under the Department of Justice, awarded a $6,500 firm fixed-price purchase order to McKesson Corporation on December 1, 2025, with an ultimate completion date of December 31, 2025. This award represents an open-market procurement with no set-aside designation. McKesson, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, will provide pharmaceutical products and medical supplies to...
- The Federal Medical Center Rochester, a civilian facility under the Department of Justice, awarded a $5,000 purchase order to McKesson Corporation on December 1, 2025, with an ultimate completion date of December 31, 2025. This firm fixed-price contract represents an open market procurement with no set-aside designation and is being performed at McKesson's location in Irving, Texas. As the nation's largest pharmaceutical distributor and a major supplier of medical products to federal agencies,...
- The Federal Medical Center Rochester awarded a $22,431.72 firm fixed-price purchase order to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, on December 18, 2025. The contract, designated as "FY26 B1 CURASCRIPT TYVASO GLOVER NOV 25," procures specialty pharmaceutical supplies for delivery to Lake Mary, Florida, with an ultimate completion date of December 18, 2025. This award utilized no set-aside designation and represents a standard...
- This is a firm fixed-price purchase order awarded by the Federal Medical Center Rochester, a civilian agency, to Mckesson Corporation, a prominent healthcare services and IT company. The contract, valued at $5,336.71, is for the delivery of pharmaceutical products, medical supplies, and healthcare solutions to support the agency's operations. The contract was awarded on April 1, 2025, with a completion date of May 23, 2025. The award is not designated as a set-aside. Mckesson Corporation is...
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $312,267.65 delivery order contract to McKesson Corporation, doing business as McKesson, to serve as the prime vendor from June 1, 2023 through August 9, 2024. McKesson will provide pharmaceutical and medical supplies on a firm fixed price basis to support the Federal Medical Center Rochester through its prime vendor program. No subcontractors were identified as participating on this contract action to...
- <p>The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $293,285.97 delivery order contract to McKesson Corporation, doing business as McKesson, to act as a prime vendor from April 1, 2023 through June 30, 2023. McKesson will provide pharmaceutical and medical supplies under a firm fixed price contract. As the qualified contracting official, the Center for Correctional Managed Care will review and approve invoices resulting from this contract action.</p>
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded McKesson Corporation a $3,465.68 delivery order for controlled substances as part of its prime vendor agreement. McKesson will provide pharmaceutical products to the facility under a firm fixed price contract running from August 1st through September 30th, 2023. As the designated Qualified Contracting Official, the Center's Contracting Officer will review and approve invoices associated with this order placed...
The U.S. Federal Medical Center Rochester, a civilian federal medical facility operated by the Department of Justice Bureau of Prisons, awarded a $38,140.38 firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on December 31, 2025. The contract, designated as B1 - PANTHERX - CRENESSITY, has no set-aside designation and extends through December 31, 2025, with performance to be executed in Pittsburgh, Pennsylvania. Pantherx Specialty Pharmacy, a Pittsburgh-based specialty pharmacy subsidiary of Centene Corporation, is registered in the System for Award Management (SAM.gov) and specializes in providing rare disease medications and customized pharmaceutical solutions to federal healthcare agencies. This award represents a continuation of Pantherx Specialty's established role as a targeted supplier of specialized medications to federal correctional facilities and veteran healthcare networks. The contractor has demonstrated consistent expertise in delivering emergency and specialized prescription pharmaceuticals to federal medical centers, with recent contract history including medications such as TARPEYO (budesonide) and other rare disease therapies. As the prime contractor on this firm fixed-price arrangement, Pantherx Specialty will leverage its specialized pharmacy capabilities to support the medical needs of Federal Medical Center Rochester inmates through the provision of pharmaceutical products under this purchase order vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.1k | 12/22/25 |